FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048754087> ?p ?o ?g. }

• W3048754087 endingPage "6827" @default.
• W3048754087 startingPage "6810" @default.
• W3048754087 abstract "AbstractDue to an outbreak of COVID-19, the number of research papers devoted to in-silico drug discovery of potential antiviral drugs is increasing every day exponentially. Still, there is no specific drug to prevent or treat this novel coronavirus (SARS-CoV-2) disease. Thus, the screening for a potential remedy presents a global challenge for scientists. Up to date over a hundred crystallographic structures of SARS-CoV-2 Mpro have been deposited to Protein Data Bank. With many known proteins, the demand for a reliable target has become higher than ever, so as the choice of an efficient computational methods. Therefore, in this study comparative methods have been used for receptor-based virtual screening, targeting 9 selected structures of viral Mpro. Reliability analyses followed by re-docking of the specific co-crystallized ligand provided the best reproductivity for structures with PDB ID 6LU7, 6Y2G and 6Y2F. The influence of crystallographic water on an outcome of a virtual screening against selected targets was also investigated. Once the most reliable targets were selected, the library of easy purchasable natural compounds were retrieved from the MolPort database (10,305 compounds) and docked against the selected Mpro proteins. To ensure the efficiency of the selected compounds, binding energies for top-15 hit ligands were calculated using Molecular Mechanics as well as their absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties were predicted. Based on predicted binding energies and toxicities, top-5 compounds were selected and subjected to Molecular Dynamics simulation and found to be stable in complex to act as possible inhibitors for SARS-CoV-2. Communicated by Ramaswamy H. SarmaKeywords: Protein reliabilitydockingmolecular dynamicsvirtual screeningnatural compoundsSARS-CoV-2 Disclosure statementThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.Additional informationFundingThe authors want to thank the National Science Foundation [Grant: NSF/CREST HRD-1547754] for financial support." @default.
• W3048754087 created "2020-08-18" @default.
• W3048754087 creator A5000573615 @default.
• W3048754087 creator A5004926206 @default.
• W3048754087 creator A5026733952 @default.
• W3048754087 creator A5027690522 @default.
• W3048754087 creator A5063698458 @default.
• W3048754087 creator A5079122928 @default.
• W3048754087 creator A5082599527 @default.
• W3048754087 date "2020-08-14" @default.
• W3048754087 modified "2023-10-17" @default.
• W3048754087 title "Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (M^pro) through docking, molecular mechanic & dynamic, and ADMET profiling" @default.
• W3048754087 cites W2009867031 @default.
• W3048754087 cites W2019436548 @default.
• W3048754087 cites W2027423337 @default.
• W3048754087 cites W2031168104 @default.
• W3048754087 cites W2079953901 @default.
• W3048754087 cites W2102377211 @default.
• W3048754087 cites W2129153475 @default.
• W3048754087 cites W2621704389 @default.
• W3048754087 cites W2801088198 @default.
• W3048754087 cites W2912818999 @default.
• W3048754087 cites W3004280078 @default.
• W3048754087 cites W3009813421 @default.
• W3048754087 cites W3009906937 @default.
• W3048754087 cites W3009970748 @default.
• W3048754087 cites W3009976289 @default.
• W3048754087 cites W3010099722 @default.
• W3048754087 cites W3010930696 @default.
• W3048754087 cites W3011698812 @default.
• W3048754087 cites W3011701533 @default.
• W3048754087 cites W3012495758 @default.
• W3048754087 cites W3012611856 @default.
• W3048754087 cites W3014850166 @default.
• W3048754087 cites W3014852814 @default.
• W3048754087 cites W3015285595 @default.
• W3048754087 cites W3015496215 @default.
• W3048754087 cites W3015608194 @default.
• W3048754087 cites W3020749996 @default.
• W3048754087 cites W3021439445 @default.
• W3048754087 cites W3025443708 @default.
• W3048754087 cites W3089874492 @default.
• W3048754087 cites W3102126867 @default.
• W3048754087 cites W3125062463 @default.
• W3048754087 cites W3149078497 @default.
• W3048754087 cites W4254348569 @default.
• W3048754087 doi "https://doi.org/10.1080/07391102.2020.1806930" @default.
• W3048754087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7484579" @default.
• W3048754087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32795148" @default.
• W3048754087 hasPublicationYear "2020" @default.
• W3048754087 type Work @default.
• W3048754087 sameAs 3048754087 @default.
• W3048754087 citedByCount "19" @default.
• W3048754087 countsByYear W30487540872020 @default.
• W3048754087 countsByYear W30487540872021 @default.
• W3048754087 countsByYear W30487540872022 @default.
• W3048754087 countsByYear W30487540872023 @default.
• W3048754087 crossrefType "journal-article" @default.
• W3048754087 hasAuthorship W3048754087A5000573615 @default.
• W3048754087 hasAuthorship W3048754087A5004926206 @default.
• W3048754087 hasAuthorship W3048754087A5026733952 @default.
• W3048754087 hasAuthorship W3048754087A5027690522 @default.
• W3048754087 hasAuthorship W3048754087A5063698458 @default.
• W3048754087 hasAuthorship W3048754087A5079122928 @default.
• W3048754087 hasAuthorship W3048754087A5082599527 @default.
• W3048754087 hasBestOaLocation W30487540872 @default.
• W3048754087 hasConcept C103697762 @default.
• W3048754087 hasConcept C104317684 @default.
• W3048754087 hasConcept C119145174 @default.
• W3048754087 hasConcept C142724271 @default.
• W3048754087 hasConcept C147597530 @default.
• W3048754087 hasConcept C159110408 @default.
• W3048754087 hasConcept C181199279 @default.
• W3048754087 hasConcept C185592680 @default.
• W3048754087 hasConcept C2775905019 @default.
• W3048754087 hasConcept C2776714187 @default.
• W3048754087 hasConcept C2779134260 @default.
• W3048754087 hasConcept C2780035454 @default.
• W3048754087 hasConcept C3007834351 @default.
• W3048754087 hasConcept C3008058167 @default.
• W3048754087 hasConcept C41685203 @default.
• W3048754087 hasConcept C41847442 @default.
• W3048754087 hasConcept C47701112 @default.
• W3048754087 hasConcept C524204448 @default.
• W3048754087 hasConcept C55493867 @default.
• W3048754087 hasConcept C59593255 @default.
• W3048754087 hasConcept C65556437 @default.
• W3048754087 hasConcept C69366308 @default.
• W3048754087 hasConcept C70721500 @default.
• W3048754087 hasConcept C71924100 @default.
• W3048754087 hasConcept C74187038 @default.
• W3048754087 hasConcept C86803240 @default.
• W3048754087 hasConcept C98274493 @default.
• W3048754087 hasConceptScore W3048754087C103697762 @default.
• W3048754087 hasConceptScore W3048754087C104317684 @default.
• W3048754087 hasConceptScore W3048754087C119145174 @default.
• W3048754087 hasConceptScore W3048754087C142724271 @default.
• W3048754087 hasConceptScore W3048754087C147597530 @default.

• next